Logo image of SRP.PA

SHOWROOMPRIVE (SRP.PA) Stock Fundamental Analysis

EPA:SRP - Euronext Paris - Matif - FR0013006558 - Common Stock - Currency: EUR

0.5  -0.01 (-1.96%)

Fundamental Rating

2

SRP gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 53 industry peers in the Specialty Retail industry. SRP may be in some trouble as it scores bad on both profitability and health. SRP does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

SRP had negative earnings in the past year.
SRP had a positive operating cash flow in the past year.
Of the past 5 years SRP 4 years were profitable.
Each year in the past 5 years SRP had a positive operating cash flow.
SRP.PA Yearly Net Income VS EBIT VS OCF VS FCFSRP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

1.2 Ratios

With a Return On Assets value of -9.85%, SRP is not doing good in the industry: 79.25% of the companies in the same industry are doing better.
SRP has a Return On Equity of -24.37%. This is in the lower half of the industry: SRP underperforms 73.58% of its industry peers.
Industry RankSector Rank
ROA -9.85%
ROE -24.37%
ROIC N/A
ROA(3y)-3.22%
ROA(5y)-0.11%
ROE(3y)-7.98%
ROE(5y)-0.56%
ROIC(3y)N/A
ROIC(5y)N/A
SRP.PA Yearly ROA, ROE, ROICSRP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

SRP's Gross Margin of 36.82% is in line compared to the rest of the industry. SRP outperforms 52.83% of its industry peers.
SRP's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for SRP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.56%
GM growth 5Y3.86%
SRP.PA Yearly Profit, Operating, Gross MarginsSRP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

SRP does not have a ROIC to compare to the WACC, probably because it is not profitable.
SRP has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, SRP has more shares outstanding
Compared to 1 year ago, SRP has an improved debt to assets ratio.
SRP.PA Yearly Shares OutstandingSRP.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SRP.PA Yearly Total Debt VS Total AssetsSRP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

SRP has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
SRP has a better Debt to Equity ratio (0.15) than 88.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC6.23%
SRP.PA Yearly LT Debt VS Equity VS FCFSRP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

2.3 Liquidity

SRP has a Current Ratio of 0.82. This is a bad value and indicates that SRP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.82, SRP is not doing good in the industry: 81.13% of the companies in the same industry are doing better.
SRP has a Quick Ratio of 0.82. This is a bad value and indicates that SRP is not financially healthy enough and could expect problems in meeting its short term obligations.
SRP has a Quick ratio (0.47) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.47
SRP.PA Yearly Current Assets VS Current LiabilitesSRP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

2

3. Growth

3.1 Past

SRP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -8321.43%.
The Revenue has decreased by -4.53% in the past year.
The Revenue has been growing slightly by 0.98% on average over the past years.
EPS 1Y (TTM)-8321.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1346.57%
Revenue 1Y (TTM)-4.53%
Revenue growth 3Y-3.7%
Revenue growth 5Y0.98%
Sales Q2Q%86.92%

3.2 Future

Based on estimates for the next years, SRP will show a very strong growth in Earnings Per Share. The EPS will grow by 27.09% on average per year.
SRP is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.64% yearly.
EPS Next Y84.21%
EPS Next 2Y42.35%
EPS Next 3Y27.09%
EPS Next 5YN/A
Revenue Next Year-5.71%
Revenue Next 2Y-1.5%
Revenue Next 3Y-1.64%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SRP.PA Yearly Revenue VS EstimatesSRP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
SRP.PA Yearly EPS VS EstimatesSRP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SRP. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SRP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SRP.PA Price Earnings VS Forward Price EarningsSRP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SRP.PA Per share dataSRP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

SRP's earnings are expected to grow with 27.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.35%
EPS Next 3Y27.09%

More info and screens

0

5. Dividend

5.1 Amount

SRP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SHOWROOMPRIVE

EPA:SRP (6/13/2025, 7:00:00 PM)

0.5

-0.01 (-1.96%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)04-30 2025-04-30
Earnings (Next)07-30 2025-07-30
Inst Owners0.36%
Inst Owner ChangeN/A
Ins Owners56.36%
Ins Owner ChangeN/A
Market Cap59.52M
Analysts50
Price Target0.79 (58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-16.22%
PT rev (3m)-13.89%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-50%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.62%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF N/A
P/OCF 4.18
P/B 0.37
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.35
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.12
OCFY23.92%
SpS5.43
BVpS1.37
TBVpS-0.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.85%
ROE -24.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.82%
FCFM N/A
ROA(3y)-3.22%
ROA(5y)-0.11%
ROE(3y)-7.98%
ROE(5y)-0.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.56%
GM growth 5Y3.86%
F-Score5
Asset Turnover1.6
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 145.9%
Cap/Sales 3.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.47
Altman-Z N/A
F-Score5
WACC6.23%
ROIC/WACCN/A
Cap/Depr(3y)90%
Cap/Depr(5y)82.36%
Cap/Sales(3y)2.07%
Cap/Sales(5y)1.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8321.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1346.57%
EPS Next Y84.21%
EPS Next 2Y42.35%
EPS Next 3Y27.09%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.53%
Revenue growth 3Y-3.7%
Revenue growth 5Y0.98%
Sales Q2Q%86.92%
Revenue Next Year-5.71%
Revenue Next 2Y-1.5%
Revenue Next 3Y-1.64%
Revenue Next 5YN/A
EBIT growth 1Y-3157.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year125.22%
EBIT Next 3Y32.91%
EBIT Next 5YN/A
FCF growth 1Y-705.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.34%
OCF growth 3Y-26.69%
OCF growth 5YN/A